Iliac Stent Market Report Examines Industry Trends, Growth Drivers And Future Outlook

The iliac stent market is poised for significant expansion over the coming years, driven by advancements in treatment options and increasing healthcare demands. As the prevalence of vascular conditions rises, this specialized segment of interventional cardiology is set to attract considerable attention from healthcare providers and industry players alike. Below is a detailed overview of the market's size, key players, evolving trends, and segmentation.

Projected Growth Trajectory of the Iliac Stent Market Through 2030
The iliac stent market is forecasted to reach a value of $1.5 billion by 2030, growing at a compound annual growth rate (CAGR) of 6.4%. This expected growth stems from the rising preference for minimally invasive procedures, the growing incidence of lifestyle-related vascular diseases, and broader availability of interventional cardiology services. Additionally, increasing healthcare spending in emerging markets, along with an emphasis on early vascular intervention, are driving demand. Key trends fueling market expansion include higher adoption rates of minimally invasive peripheral interventions, a growing preference for self-expandable iliac stents, and increasing use of drug-eluting and covered stents for complex lesions. The shift toward outpatient and day-care endovascular procedures, as well as the broader application of iliac stents in severe and calcified arterial lesions, also contribute to this positive outlook.

Download a free sample of the iliac stent market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15827&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Jul_PR

Important Factors Stimulating Demand in the Iliac Stent Market
The growing incidence of vascular diseases linked to lifestyle factors like obesity and diabetes is a significant contributor to the increased use of iliac stents. As these conditions become more common globally, there is a heightened need for effective and less invasive treatment options that can improve patient outcomes.
Furthermore, expanding access to advanced interventional cardiology treatments, especially in developing economies, is encouraging more widespread adoption of iliac stents. Rising healthcare budgets and increasing awareness about early diagnosis and intervention strategies are also playing crucial roles in market growth.

Key Leaders Steering the Iliac Stent Industry
The iliac stent market features several prominent companies that dominate the competitive landscape. These include Cardinal Health Inc., Abbott Laboratories, Medtronic Plc, Becton dic*kinson and Company, Boston Scientific Corporation, B. Braun Melsungen AG, Terumo Corporation, W. L. Gore & Associates Inc., C. R. Bard Inc., Getinge AB, Cook Medical LLC, Biotronik SE & Co. KG, MicroPort Scientific Corporation, Cordis Corporation, Endologix Inc., LeMaitre Vascular Inc., Alvimedica, Clearstream Technologies Ltd., Jotec GmbH, Translumina GmbH, Vascular Concepts Limited, Lombard Medical Technologies, Acandis GmbH, Gore Medical, and Medizintechnik GmbH.

View the full iliac stent market report:
https://www.thebusinessresearchcompany.com/report/iliac-stent-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Jul_PR

Significant Acquisition Enhancing Market Position
In February 2023, Abbott Laboratories, a US-based pharmaceutical giant, acquired Cardiovascular Systems Inc. (CSI), a medical technology company specializing in iliac stents, for an undisclosed sum. This acquisition is intended to expand Abbott's vascular device portfolio by incorporating CSI's cutting-edge atherectomy system, strengthening its position in the vascular treatment segment.

Emerging Innovations and Trends Shaping the Iliac Stent Market
Leading market players are focusing on innovative product development to improve patient outcomes and minimize complications. For example, the iCast-covered stent system represents a breakthrough in treating iliac artery occlusive disease by offering enhanced performance compared to conventional bare-metal stents.
Highlighting this trend, in October 2023, Sweden's Getinge announced the FDA approval and commercial launch of its iCast-covered stent system in the US, designed specifically for treating iliac arterial occlusive disease. This advancement demonstrates Getinge's dedication to delivering effective solutions and supporting clinicians in managing complex vascular conditions.

Detailed Segmentation of the Global Iliac Stent Market
This report segments the iliac stent market into various categories to provide a comprehensive understanding of its structure:

1) By Type:
- Self-Expandable Stents
- Balloon-Expandable Stents
- Other Types

2) By Artery Lesions:
- Common Iliac Artery Lesions
- Severe Calcified Lesions

3) By End-Users:
- Hospitals
- Outpatient Facilities
- Other End-Users

Further breakdown of stent types includes:
- Self-Expandable Stents: Nitinol Self-Expandable Stents, Polymer-Coated Self-Expandable Stents
- Balloon-Expandable Stents: Bare-Metal and Drug-Eluting Balloon-Expandable Stents
- Other Types: Covered Stents and Hybrid Stents

This segmentation provides insight into product preferences, applications, and user environments, helping stakeholders make informed decisions in this evolving market.

Our 2026 market reports now feature expanded strategic intelligence through market attractiveness scoring and analysis, total addressable market (TAM) analysis, company scoring matrix graphics and tables, Excel-based dashboards, market hotspots infographics, key technology and future trend analysis, along with updated graphics and tables.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 30,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.